Dr. Kamal Sharma & Milind Sarwate Reappointed As Independent Directors Of Sequent Scientific

Sequent Scientific Limited has reappointed Dr. Kamal Sharma and Milind Sarwate as Non-Executive Independent Directors, effective August 25, 2025, subject to shareholder approval.

Dr. Kamal Sharma brings over five decades of experience in the chemical and pharmaceutical industries. He served as the Managing Director of Lupin from 2003 to 2013, leading its transformation into a prominent global pharmaceutical company. Prior to that, he was President & Chief Executive of the Life Sciences and Speciality Group at RPG Enterprises and a member of its Management Board. Dr. Sharma holds a bachelor’s degree in chemical engineering from IIT Kanpur, a postgraduate diploma in industrial management from JBIMS, Mumbai, and a PhD in economics from IIT Bombay. He also completed the Advanced Management Program at Harvard Business School. His expertise spans operations, corporate strategy, and executive leadership in highly regulated industries.

Milind Sarwate is the Founder of Increate, an advisory platform focused on governance, ESG, and capability building. He currently serves as an Independent Director on the Boards of Asian Paints, Mahindra Finance, CEAT, Nykaa, and Hexaware and has held similar roles in Mindtree and International Paper. With over 42 years of experience, he has held leadership roles as CFO and CHRO at Marico and Godrej. Sarwate is a Chartered Accountant, Cost Accountant, Company Secretary, and a CII-Fulbright Fellow. His boardroom expertise lies in governance, ESG, and audit committees. Known for his role in bridging business and social value, he has been associated with listed company Boards since 2005.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: